01506nas a2200193   4500000000100000008004100001260003800042653002800080653002200108653003100130653002600161653001500187100001400202700001600216245003900232300001000271520101300281020001801294       2023                            d  bSpringer International Publishing10aHealth status indicator10aBurden of Disease10aNeglected tropical disease10aQuantitative analysis10aIncidence.1 aIgnotti E1 aSteinmann P00aEpidemiology of Hansen’s Disease  a59-643 a<p>This chapter presents a current discussion on the epidemiology of HD-based standardized indicators of the burden of disease—incidence, prevalence, relapse—combined with indicators related to operational aspects. The latter describe the quality of the health services relevant for the HD program—including the proportion of cases evaluated and diagnosed with disabilities, the proportion cured, and the number of those abandoning treatment. Cases with worsening disabilities during and after MDT, misdiagnosis, and death due to HD are also relevant for the quality of the program. We considered the impacts of the COVID-19 pandemic response, demanding new strategies to reduce the burden of HD as part of the group of Neglected Tropical Diseases. The base for the future interruption of transmission is provided by the introduction of new diagnostic tests in combination with the existing tools for active case detection, and the scaling up of leprosy prevention with post-exposure prophylaxis.</p>
  a9783031308925